NexGel Inc (NXGL) AI Stock Analysis

• Market Cap: $24.17M
• Dividend Yield: N/A
• Average Volume (3M): 46.03K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.95
• Revenue Growth: 115.94%
• EPS Growth: 17.42%
• Country: US
• Employees: 19
• Sector: Healthcare
• Sector Strength: 48
• Industry: Medical - Instruments & Supplies
• EPS (TTM): -0.09
• Shares Outstanding: 7,654,537
• 10 Day Avg. Volume: 45,827
• 30 Day Avg. Volume: 46,028
• PEG Ratio: 0.08
• Price to Book (P/B): 2.57
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -3.07
• Enterprise Value/Market Cap: 0.50
• Enterprise Value/Revenue: 0.40
• Enterprise Value/Gross Profit: 3.33
• Enterprise Value/Ebitda: -0.99
• 1Y Price Target: $6.00
• Price Target Upside: 154.24% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 48 Neutral
• Price Target: $2.50 ▲(5.93%Upside)

NexGel Inc's overall stock score is primarily influenced by strong revenue growth and positive sentiment from the recent earnings call, mitigating some concerns about ongoing financial losses and weak valuation metrics. However, the company's technical analysis suggests a bearish trend, and its valuation remains unattractive due to a negative P/E ratio and lack of dividends.

Positive Factors

Financial Health

NexGel ended the period with $1.81M in cash and no debt, which should fund the company until positive cash flow is achieved.

Revenue Growth

NexGel reported a significant revenue increase of 122% year-over-year, aligning with guidance and surpassing estimates.

Strategic Initiatives

Several initiatives are driving growth, including partnerships and new product launches, particularly in the Medagel/SilverSeal and Silly George brands.

Negative Factors

Operating Expenses

Operating expenses were higher than expected due to auditing and temporary accounting department expenses.

NexGel Inc Business Overview & Revenue Model

Company Description

NexGel Inc (NXGL) is a leading provider in the advanced hydrogel solutions industry. The company specializes in the research, development, and manufacturing of high-performance hydrogels for various applications, including medical, consumer, and industrial sectors. NexGel's core products include innovative hydrogel-based products used in wound care, transdermal drug delivery, and various other specialty applications where the unique properties of hydrogels offer significant benefits.

How the Company Makes Money

NexGel Inc generates revenue through the sale of its proprietary hydrogel products and formulations. The company's primary revenue streams include direct sales to healthcare providers and manufacturers who incorporate NexGel's hydrogels into their products. Additionally, NexGel may engage in partnerships and collaborations with other companies to co-develop or license its technology, further broadening its market reach and revenue potential. Key factors contributing to its earnings include the growing demand for advanced wound care and transdermal drug delivery solutions, as well as its ability to innovate and adapt its hydrogel technologies to meet diverse market needs.

NexGel Inc Financial Statement Overview

Summary

NexGel Inc shows strong revenue growth, indicating potential in its core business operations. However, persistent net losses and negative cash flows suggest challenges in achieving profitability and financial stability. The balance sheet is stable with a reasonable equity position, but the company must address profitability issues to improve its financial health.

Income Statement

NexGel Inc has experienced significant revenue growth over the years, with a notable increase from 2023 to 2024. However, the company continues to report negative net income, leading to a negative net profit margin. The gross profit margin has improved, but operating losses remain a concern, reflected in negative EBIT and EBITDA margins. The improvement in revenue is overshadowed by persistent losses, impacting overall profitability.

Balance Sheet

The company maintains a moderate debt-to-equity ratio with an increasing stockholders' equity base, indicating a stable equity position. However, the return on equity remains negative due to ongoing net losses, which is concerning. The equity ratio is healthy, suggesting that the company is not overly reliant on debt financing. Despite these positive aspects, the inability to generate net income affects overall stability.

Cash Flow

NexGel Inc's cash flow statements show negative operating and free cash flows, indicating operational challenges. Despite this, the company has managed to secure financing, which has supported cash flow needs. However, the inability to generate positive free cash flow to net income ratio highlights the ongoing struggles in achieving cash flow profitability.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
10.23M	8.69M	4.09M	2.05M	1.55M	674.00K
	Gross Profit
3.66M	2.75M	619.00K	256.00K	9.00K	-291.00K
	EBIT
-3.46M	-3.55M	-3.48M	-3.35M	-2.57M	-2.26M
	EBITDA
-2.89M	-3.55M	-2.73M	-3.11M	-2.20M	-2.20M
	Net Income Common Stockholders
-3.14M	-3.28M	-3.16M	-6.14M	-6.31M	-2.28M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
0.00	1.81M	2.70M	6.61M	13.35M	32.00K
	Total Assets
1.69M	10.98M	9.96M	10.36M	16.98M	2.26M
	Total Debt
1.00M	2.83M	2.80M	2.08M	4.26M	1.28M
	Net Debt
1.00M	1.02M	98.00K	982.00K	-9.09M	1.25M
	Total Liabilities
1.46M	4.90M	4.79M	2.72M	4.90M	2.19M
	Stockholders Equity
225.00K	5.75M	4.70M	7.64M	12.09M	71.00K
Cash Flow		Free Cash Flow
-3.47M	-4.31M	-3.93M	-3.09M	-3.02M	-2.11M
	Operating Cash Flow
-3.17M	-3.87M	-3.24M	-2.99M	-2.75M	-1.80M
	Investing Cash Flow
-657.00K	-775.00K	4.46M	-5.59M	-269.00K	-312.00K
	Financing Cash Flow
2.60M	3.75M	379.00K	-3.66M	16.34M	1.88M

NexGel Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.36
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NXGL, the sentiment is Negative. The current price of 2.36 is above the 20-day moving average (MA) of 2.31, below the 50-day MA of 2.48, and below the 200-day MA of 3.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.30 is Neutral, neither overbought nor oversold. The STOCH value of 48.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NXGL.

NexGel Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NEPH	61 Neutral	$37.95M	66.23	9.17%	―	10.34%	―
Sector *	53 Neutral	$5.24B	3.32	-44.36%	6.63%	16.78%	-0.12%
HBIO	51 Neutral	$21.57M	―	-138.80%	―	-14.41%	-549.88%
NXGL	48 Neutral	$24.17M	―	-62.82%	―	115.94%	17.42%
AKYA	47 Neutral	$64.94M	―	-354.27%	―	-14.55%	34.87%
RVP	46 Neutral	$19.79M	―	-25.89%	―	-16.05%	-195.28%
FEMY	40 Underperform	$25.65M	―	-239.87%	―	61.97%	-6.89%

NexGel Inc Corporate Events

NexGel Inc Stockholders Approve Key Proposals at Meeting

NexGel, Inc. held its 2025 Annual Meeting of Stockholders on June 17, 2025, where stockholders approved several key proposals. The Fourth Amendment to the 2019 Long-Term Incentive Plan was approved, increasing the authorized common stock by 780,000 shares. Additionally, five directors were elected, executive compensation was approved, and the appointment of Turner, Stone & Company, LLP as the independent registered public accounting firm for 2025 was ratified.

The most recent analyst rating on (NXGL) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on NexGel Inc stock, see the NXGL Stock Forecast page.